FindTrial
Sign In

To study the effect of Siravedha in Padadari.

Clinical study to evaluate the efficacy of Siravedha in Padadari. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075739
Enrollment
45
Registered
2024-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D759- Disease of blood and blood-formingorgans, unspecified

Interventions

None listed

Sponsors

Tilak ayurveda mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients having samanya lakshan (padasphutan, vedana, rukshata, daha) of padadari. irrespective of sex, religion, and occupation.

Exclusion criteria

Exclusion criteria: patients who are contraindicated for siravedh. patients with infectious disorders like HIV, hepatitis B, tuberculosis are excluded. suffering from psoriasis, diabetes, plantar fascitis, and any other dermal leisions.

Design outcomes

Primary

MeasureTime frame
To determine the effect of siravedha in the management of padadari.Timepoint: 18 Months—

Secondary

MeasureTime frame
Study the side effects of siravedha, if any.Timepoint: 18 Months—

Countries

India

Contacts

Public ContactVd. Anjali Vinayak Damle

Tilak ayurved mahavidyalaya

anjali.damle@yahoo.in9518504373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026